Overview
As you may be aware, Warfarin is the main Anticoagulation treatment for the prevention of stroke and thromboembolic conditions in certain patients with Atrial Fibrillation (AF). Recently published NICE (National Institute for Health and Clinical Excellence) draft guidelines permit the use of new oral anticoagulation drugs (NOACs), along with other risk factors their use is likely to be based on INR (International Normalised Ratio) control. Vision+ Anticoagulation Manager contains tools for managing all aspects of anticoagulation regardless of the patient's drug regime. It includes Adverse Event Reporting, advice on Dosing regimes and presents supporting materials for structured Education and Reviews.
When you select a patient in Consultation Manager an alert window will warn if the patient is missing essential anticoagulation information that will assist in the management of their care. There is also an easy to use Clinical Template where you can quickly record relevant information. In addition, a suite of reports will capture data and provide a comprehensive reporting tool.
Anticoagulation Manager comprises of:
- Alerts for missing/due data
- Anticoagulation Templates which include:
- Anticoagulation Therapy management screen
- Warfarin management and dosing tool
- Diagnosis Indication screen
- INR monitoring screen
- Management screen for New Oral Anticoagulant Drugs
- Other Assessment screen showing other factors that may affect the patient's anticoagulant treatment
- Reporting facility which allows you to work on patient lists or create a mail merge
This guide explains how to access the alert window and record data in the Anticoagulation Manager template. It also provides details of the reports that can be used to monitor your patients.
